An Open-Label Phase 1 Study to Investigate PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors
This study will test the safety of a drug called PF-08046031 in participants with melanoma and other solid tumors that have no current approved treatment or have spread through the body. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. The study will have 3 parts. Part A and B of the study will find out how much PF-08046031 should be given to participants. Part C will use the information from Parts A and B to see if PF-08046031 is safe and if it works to treat solid tumor cancers.
100 项与 PF-08046031 相关的临床结果
100 项与 PF-08046031 相关的转化医学
100 项与 PF-08046031 相关的专利(医药)
100 项与 PF-08046031 相关的药物交易